Australian researchers have created building blocks out of DNA to construct a series of nano-scale objects and shapes, from a rod and a square to an infinitesimally small dinosaur.
The approach turns DNA into a modular material for building nanostructures – thousands of times narrower than a human hair. Developed by researchers from the University of Sydney Nano Institute and published in the journal Science Robotics, it suggests exciting possibilities for future use of nanobot technology.
This video explores fascinating engineering solutions hiding in plain sight — ingenious designs that solve complex problems through elegant simplicity. From shoes that expand when stretched to windshields with hidden patterns, discover how everyday objects incorporate remarkable engineering innovations.
AUXETICS These metamaterials that defy conventional physics by getting thicker when stretched. Follow their evolution from theoretical designs in 1978 to modern applications in athletic footwear and medical devices, and discover how precise geometric patterns create extraordinary properties that could revolutionize everything from prosthetics to architecture, despite challenging manufacturing requirements.
WINDSHIELD DOTS The black dots on car windshields serve a dual purpose that revolutionized the automotive industry in the 1950s. This pattern manages extreme thermal stress during glass tempering while protecting crucial adhesive bonds. The precise ceramic frit application process has evolved to support modern safety systems and sensor integration, making these simple dots essential to modern vehicle design.
CURIE POINT HEATERS Curie point heaters achieve temperature control through magnetic properties alone, eliminating complex control systems. These heaters maintain precise temperatures by becoming “magnetically invisible” at specific points. Modern implementations use sophisticated alloy combinations and multi-layer designs for unprecedented temperature control in medical sterilization and semiconductor processing.
A quiet revolution is brewing in labs around the world, where scientists’ use of AI is growing exponentially. One in three postdocs now use large language models to help carry out literature reviews, coding, and editing. In October, the creators of our AlphaFold 2 system, Demis Hassabis and John Jumper became Nobel Laureates in Chemistry for using AI to predict the structure of proteins, alongside the scientist David Baker, for his work to design new proteins. Society will soon start to feel these benefits more direct ly, with drugs and materials designed with the help of AI currently making their way through development.
In this essay, we take a tour of how AI is transforming scientific disciplines from genomics to computer science to weather forecasting. Some scientists are training their own AI models, while others are fine-tuning existing AI models, or using these models’ predictions to accelerate their research. Scientists are using AI as a scientific instrument to help tackle important problems, such as designing proteins that bind more tightly to disease targets, but are also gradually transforming how science itself is practised.
There is a growing imperative behind scientists’ embrace of AI. In recent decades, scientists have continued to deliver consequential advances, from Covid-19 vaccines to renewable energy. But it takes an ever larger number of researchers to make these breakthroughs, and to transform them into downstream applications. As a result, even though the scientific workforce has grown significantly over the past half-century, rising more than seven fold in the US alone, the societal progress that we would expect to follow, has slowed. For instance, much of the world has witnessed a sustained slowdown in productivity growth that is undermining the quality of public services. Progress towards the 2030 Sustainable Development Goals, which capture the biggest challenges in health, the environment, and beyond, is stalling.
Researchers at the University of Twente, Netherlands, have made an advancement in bioprinting technology that could transform how we create vascularized tissues. Their innovative bioink, recently featured in Advanced Healthcare Materials, introduces a way to precisely guide the growth and organization of tiny blood vessels within 3D-bioprinted tissues. The tiny blood vessels mimic the intricate networks found in the human body.
3D-printed organs have the potential to revolutionize medicine by providing solutions for organ failure, and tissue damage and developing new therapies. But a major challenge is ensuring these printed tissues receive enough nutrients and oxygen, which is critical for their survival and function. Without blood vessels, these tissues can’t efficiently obtain nutrients or remove waste, limiting their effectiveness. Therefore, the ability to 3D-bioprint blood vessels is a crucial advancement.
Tissue engineers could already position blood vessels during the bioprinting process, but these vessels often remodel unpredictably when cultured in the lab or implanted in the body, reducing the effectiveness of the engineered tissue. The programmable bioink developed by the University of Twente team addresses this issue by providing dynamic control over vessel growth and remodeling over time. This opens new possibilities for creating engineered tissues with long-term functionality and adaptability.
Bill Faloon discusses advancements in age reversal therapies and their transition from research to clinical application, emphasizing the potential for delaying and reversing biological aging. He highlights advancements in age reversal, discussing therapies like young plasma, gene editing, yamanaka factors and exosome treatments, emphasizing their potential to reverse aging, improve health, and extend lifespan.
Please note that the links below are affiliate links, so we receive a small commission when you purchase a product through the links. Thank you for your support! =*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*= 🔖Stem Cells Enhancers : STEMREGEN 15% OFF CODE: REVERSE : https://stemregen.co/reverse.
Linda Jiang is Head of Strategy and Government Partnerships, Healthcare, at Lyft (https://www.lyft.com/healthcare), where she’s responsible for accelerating the growth of the business, driving public sector strategy, and partnering with policymakers and regulators to bring access to the rideshare service to millions of people who need it for healthcare access.
Previously, Linda was an early growth operator at healthcare startups, leading strategy for Modern Fertility and consumer marketing for Color Genomics.
Linda began her career as a management consultant at PwC, with clients including academic medical centers, top integrated healthcare systems, medical device companies, and big box retailers, and also had a role in corporate strategy at Twitter.
She holds a Master of Public Health (MPH) and a Bachelor of Science, Neuroscience and Behavioral Biology from Emory University.
Researchers from CSIR-Central Leather Research Institute (CLRI), supported by INSPIRE Faculty and WISE Kiran Fellowships, explored the chemistry between proteins and nanozymes to advance artificial enzymes. Their work focuses on using manganese-based oxidase nanozyme (MnN) to crosslink collagen, a key structural protein, aiming to develop biomaterials for future medicinal and biomedical applications.